Qa Qc News Today

In a remarkable development, Front Line Medical Technologies Inc., an innovator in trauma care medical devices, has announced the attainment of CE marking for its COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System).

Celadon Pharmaceuticals has today (December 14) announced its first supply of it pharmaceutical-grade breakthrough cannabis-based medicine.

Quality assurance/quality control (QA/QC) is integral to bearings manufacturing, upholding industry standards and contributing to overall effectiveness.

JRS Pharma is a leading manufacturer of excipients, offering a complete portfolio of excipient solutions for the pharmaceutical and nutraceutical industries. Our excipients portfolio includes: high functionality excipients, binders, disintegrants, lubricants, functional fillers, thickeners, stabilizers, gelling agents, carriers, and coatings.

GURUGRAM, India, Nov. 15, 2022 /PRNewswire/ --Xebia, an IT Consultancy and Software Development Company has acquired Netlink Digital Solutions Group (NDS) from Netlink Software Group America (Netlink), an IT organization with its headquarter in Detroit, Michigan. NDS is a leading provider of Low Code digital transformation services primarily for OutSystems platform. Xebia's interest in Netlink Digital Solutions revolves around two key aspects. First, complete end-to-end Digital Transformatio...

Join SolidSpac3, Lidar News, and Dome Construction to discuss how adding QA/QC to the BIM workflow reduces errors and boosts project ROI...

A leader from the company discusses challenges in control labs and shares how a new solution aims to clear some key obstacles to greater effectiveness.

With the amount of available data increasing and technology evolving, says a company leader, the job of data manager is more demanding than ever before.

A leader from the information technology specialist explains how evolved thinking and digital transformation are leading to benefits across the industry.

A leader from the R&D tech provider discusses the obstacles faced by drug development professionals in recent months, and ways they rose to the occasion.